Pharmaceutical industry – Page 53
-
News
Pharma should 'double output by 2022'
US report says pharma industry must set itself an ambitious target for drug development
-
Business
Regorafenib approved in US
Stivarga tablets approved for treatment of advanced colorectal cancer
-
-
Business
Sanofi to cut 900 jobs in France
Number of jobs to be cut reduced from 2500 to 900 following outcry
-
Business
Pineapple gel approved for burns
EU regulators approve NexoBrid gel from MediWound for removal of scab tissue
-
NewsEU tightens drug rules in wake of Mediator scandal
Withdrawal of a drug in one EU member state will trigger an alert throughout the rest
-
Business
Bayer $145 million animal health deal
Move will strengthen anti-infective portfolio and introduce reproductive hormones
-
NewsOrphan drugs set for 'tremendous growth'
Drugs for rare diseases are rapidly becoming very profitable with growth predicted to outstrip non-orphan drugs
-
NewsChinese drug makers accused of using ‘gutter oil’
Oil reclaimed from drains may have been used to make an antibiotic intermediate
-
-
NewsDrug maker apologises for thalidomide tragedy
Fifty years after the event Grünenthal issues an apology as victims of the drug continue to press for compensation
-
Business
Myelofibrosis drug approved in EU
Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
OpinionMonopoly money
Dean Baker says it’s time to start talking seriously about the way in which pharma is funded
-
OpinionProtecting patients at all costs
Suffering stagnant output, and beset by patent expiries and spiralling costs, drug discovery is in poor health. Simon Campbell prescribes a remedy
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets